LaFleur imports 500 Cannabis cuttings

LaFleur, a French medical cannabis company, has imported 500 cuttings of 24 different cannabis strains as part of the Cannatech project, which is supported by the Pays de la Loire region through a grant of €800,000.

The Cannatech Project

The Cannatech project focuses on optimizing cannabis production in collaboration with INRAe, the University of Angers, and the company SERAAP.

The challenge is to efficiently produce the target compounds for medical cannabis in a controlled environment and to reduce resource consumption in order to achieve environmentally responsible production of the highest quality.

LaFleur is thus developing analytical methods in collaboration with the SONAS (Substances of Natural Origin and Structural Analogues) laboratory at the University of Angers, which enable it to characterize varieties and select them based on their active molecule profiles.

In parallel with the Cannatech project, green chemistry-based extraction techniques have been under development since 2019 through a partnership with the École Nationale Supérieure des Ingénieurs en Arts Chimiques et Technologiques de Toulouse (ENCIACET).

The formulation and production of pharmaceutical dosage forms are handled by French partners.

Smart Lab

DelleD-LaFleur has developed smart climate-controlled rooms using its proprietary Hortimind AI solution, which automates the monitoring and optimization of cannabis crops.

«Through its partners, DelleD is already able to supply medical cannabis that is produced and regulated in Europe.".

The importation of cannabis cuttings »and the implementation of the agronomic R&D program will enable our laboratory to offer French cannabis-based therapeutic solutions within the next 12 months, pending the granting of authorizations," said Franck Milone, President and Founder of DelleD.

After raising an initial €3 million and securing €500,000 in funding from the BPI and the Île-de-France region in 2020, as well asa grant of approximately €800,000 from the Pays de la Loire region in 2022, DelleD is currently finalizing a new €1.1 million funding round and launching a €10 million Series A round to accelerate its growth and prepare for the widespread adoption of medical cannabis in France by March 2024.